Eco-Pharmaco-Stewardship – EPS

Leading organisations:
Inter-Association Initiative on Pharmaceuticals in the Environment - IAI PIE

Timeframe:
2015-2018

Geographic Area:
Pan-European

Objectives:

To gain new knowledge on the environmental safety of pharmaceuticals, consequently improving appraisal of the issue and reducing emissions of pharmaceuticals in the environment


Target audience:
Pharmaceutical manufacturers

Area of interest:
Pharmaceutical manufacturing and Risks to ecosystems

Activities:

The project entails the following activities: 1) IMI iPIE project: the identification of the potential environmental risks of existing and new active pharmaceutical ingredients (API) through intelligent and targeted assessment strategies; 2) Manufacturing effluents management: the compilation of best industry practices enabling manufacturers to minimize risks to the environment; 3) Extended ERA: the refinement of the existing environmental risk assessment (ERA) process for medicinal products to ensure that they remain up-to-date and relevant


Communication material:

Return to search form.

HCWH Europe gratefully acknowledges the financial support of the European Commission (EC)’s LIFE+ programme, the Federal Ministry for the Environment, Nature Conservation, and Nuclear Safety (BMU) Germany, and the German Environment Agency (UBA). HCWH Europe is solely responsible for the content of this project and related materials. The views expressed do not reflect the official views of the EC, BMU, or UBA.